# ALTAMIRA THERAPEUTICS LTD (CYTO)

> Institutional ownership reported to the SEC as of Q3 2023, from Form 13F filings. Source: https://holderbook.com/stocks/CYTO/

- Reporting holders: 8
- Reported value: $217.2K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [ARMISTICE CAPITAL, LLC](https://holderbook.com/funds/1601086-armistice-capital-llc/) | $202.7K | 829,000 | 0.0% | 1 |
| [CITADEL ADVISORS LLC](https://holderbook.com/funds/1423053-citadel-advisors-llc/) | $9.4K | 39,165 | 0.0% | 2 |
| [SUSQUEHANNA INTERNATIONAL GROUP, LLP](https://holderbook.com/funds/1446194-susquehanna-international-group-llp/) | $2.5K | 10,185 | 0.0% | 1 |
| [XTX Topco Ltd](https://holderbook.com/funds/1828301-xtx-topco-ltd/) | $2.4K | 10,131 | 0.0% | 1 |
| [MORGAN STANLEY](https://holderbook.com/funds/895421-morgan-stanley/) | $122 | 500 | 0.0% | 4 |
| [GROUP ONE TRADING, L.P.](https://holderbook.com/funds/932540-group-one-trading-l-p/) | $72 | 298 | 0.0% | 2 |
| [WELLS FARGO & COMPANY/MN](https://holderbook.com/funds/72971-wells-fargo-company-mn/) | $6 | 25 | 0.0% | 4 |
| [Stonebridge Capital Advisors LLC](https://holderbook.com/funds/1600035-stonebridge-capital-advisors-llc/) | $1 | 5 | 0.0% | 4 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2023 | 8 | $217.2K |
| Q2 2023 | 5 | $47.3K |
| Q1 2023 | 6 | $7.3K |
| Q4 2022 | 6 | $83.5K |
| Q3 2022 | 10 | $130.0K |
| Q2 2022 | 11 | $161.0K |
| Q1 2022 | 14 | $746.0K |
| Q4 2021 | 16 | $1.5M |
| Q3 2021 | 15 | $1.4M |